Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial

Autor: Kessoku, Takaomi, Imajo, Kento, Kobayashi, Takashi, Ozaki, Anna, Iwaki, Michihiro, Honda, Yasushi, Kato, Takayuki, Ogawa, Yuji, Tomeno, Wataru, Kato, Shingo, Higurashi, Takuma, Yoneda, Masato, Kirikoshi, Hiroyuki, Kubota, Kazumi, Taguri, Masataka, Yamanaka, Takeharu, Usuda, Haruki, Wada, Koichiro, Kobayashi, Noritoshi, Saito, Satoru, Nakajima, Atsushi *
Zdroj: In The Lancet Gastroenterology & Hepatology November 2020 5(11):996-1007
Databáze: ScienceDirect